SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-20-000196
Filing Date
2020-02-26
Accepted
2020-02-26 17:02:55
Documents
1
Group Members
ALEXANDER J. DENNER, PH.D.SARISSA CAPITAL ATHENA FUND LTDSARISSA CAPITAL CATAPULT FUND LLCSARISSA CAPITAL HAWKEYE FUND LPSARISSA CAPITAL OFFSHORE MASTER FUND LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A, AMENDMENT #1 s13da1.htm SC 13D/A 143984
  Complete submission text file 0000899140-20-000196.txt   145682
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Subject) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85292 | Film No.: 20656870
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

IRS No.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A